The Discounted Cash Flow (DCF) valuation of China National Medicines Corp Ltd (600511.SS) is 40.37 CNY. With the latest stock price at 29.93 CNY, the upside of China National Medicines Corp Ltd based on DCF is 34.9%.
Based on the latest price of 29.93 CNY and our DCF valuation, China National Medicines Corp Ltd (600511.SS) is a buy. buying 600511.SS stocks now will result in a potential gain of 34.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.6% | 7.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 32.53 - 56.91 | 40.37 |
| Upside | 8.7% - 90.1% | 34.9% |